BioCentury
ARTICLE | Clinical News

DynaGraft II regulatory update

April 11, 2005 7:00 AM UTC

FDA granted 510(k) clearance for ISON's DynaGraft II product family for orthopedic applications. The bone graft substitute is derived from demineralized bone matrix (DBM) and is delivered via a revers...